Pharmabiz

Merck reports positive results from phase 3 trial of once-daily, oral, two-drug, single-tablet regimen of Doravirine/Islatravir in treatment-naïve adults with HIV-1 infection

Merck reports positive results from phase 3 trial of once-daily, oral, two-drug, single-tablet regimen of Doravirine/Islatravir in treatment-naïve adults with HIV-1 infection ...
Pharmabiz

Medanta launches film to create awareness around prostate cancer

Medanta launches film to create awareness around prostate cancer: Our Bureau, Mumbai Thursday, November 20, 2025, 17:25 Hrs [IST] Medanta, one of India’s leading super-specialit ...
Pharmabiz

Actimed Therapeutics inks licensing agreement with Mankind Pharma

Actimed Therapeutics inks licensing agreement with Mankind Pharma: Our Bureau, Bengaluru Thursday, November 20, 2025, 17:15 Hrs [IST] Actimed Therapeutics, a UK based clinical sta ...
Pharmabiz

Tonix Pharma announces US commercial availability of Tonmya as a first-in-class fibromyalgia treatment

Tonix Pharma announces US commercial availability of Tonmya as a first-in-class fibromyalgia treatment: Chatham, New Jersey Thursday, November 20, 2025, 17:00 Hrs [IST] Tonix Phar ...
Pharmabiz

Fortis Hospitals holds CPR training to strengthen community emergency response; trained around 4,000 across hospitals and community venues

Fortis Hospitals holds CPR training to strengthen community emergency response; trained around 4,000 across hospitals and community venues: Our Bureau, Bengaluru Thursday, Novembe ...
Pharmabiz

ISGPN with scientific support from Intuitive notes robotic assisted surgery improves quality of life in kidney cancer cases

ISGPN with scientific support from Intuitive notes robotic assisted surgery improves quality of life in kidney cancer cases: Our Bureau, Bengaluru Thursday, November 20, 2025, 16: ...
Pharmabiz

Mindbowser bolsters its AWS partnership with EHRConnect to offer secure cloud solution for global healthcare sector

Mindbowser bolsters its AWS partnership with EHRConnect to offer secure cloud solution for global healthcare sector: Our Bureau, Bengaluru Thursday, November 20, 2025, 16:10 Hrs [ ...
Pharmabiz

Phase 2 trial results show potential to shorten TB treatment time

Phase 2 trial results show potential to shorten TB treatment time: Copenhagen Thursday, November 20, 2025, 16:00 Hrs [IST] New clinical trial results presented by TB Alliance at t ...
Pharmabiz

NIHR to support the Men’s Health Strategy through research

The NIHR has reaffirmed its commitment to men's health by laying out key research priorities and planned investments as part of the government’s national Men’s Health Strategy. The strategy outlines ...
Pharmabiz

Healthium Medtech inks MoU with APEDB to expand manufacturing operations in Sri City

Healthium Medtech inks MoU with APEDB to expand manufacturing operations in Sri City: Our Bureau, Benglauru Thursday, November 20, 2025, 14:50 Hrs [IST] Healthium Medtech, a globa ...
Pharmabiz

SeQuent Scientific and Viyash Lifesciences receive NCLT approval for merger

SeQuent Scientific and Viyash Lifesciences receive NCLT approval for merger: Our Bureau, Mumbai Thursday, November 20, 2025, 14:40 Hrs [IST] SeQuent Scientific Ltd, a leading play ...
Pharmabiz

C-CAMP–anchored India AMR Innovation Hub now innovation arm of India’s National Action Plan on AMR

C-CAMP–anchored India AMR Innovation Hub now innovation arm of India’s National Action Plan on AMR: Our Bureau, Bengaluru Thursday, November 20, 2025, 14:30 Hrs [IST] Centre f ...